The 18 kDa translocator protein influences angiogenesis, as well as aggressiveness, adhesion, migration, and proliferation of glioblastoma cells

Pharmacogenetics and Genomics

Volumn 22, Issue 7, 2012, Pages 538-550

  Bode, Julia ^a   Veenman, Leo ^b   Caballero, Beatriz ^b   Lakomek, Max ^a   Kugler, Wilfried ^a   Gavish, Moshe ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

18 kDa translocator protein; adhesion; angiogenesis; glioblastoma; migration

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRINOGEN; FIBRONECTIN; LAMININ 1; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

MUS MUSCULUS;

EID: 84862753717     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283539cdc     Document Type: Article

References (74)

1. Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med 2011; 13:e17.
2. Linkous AG, Yazlovitskaya EM. Angiogenesis in glioblastoma multiforme: navigating the maze. Anticancer Agents Med Chem 2011; 11:712-718.
3. Cornu P, Benavides J, Scatton B, Hauw JJ, Philippon J. Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study. Acta Neurochir (Wien) 1992; 119:146-152. (Pubitemid 23022785)
4. Veenman L, Levin E,Weisinger G, Leschiner S, Spanier I, Snyder SH, et al. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem Pharmacol 2004; 68:689-698. (Pubitemid 38953450)
5. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51:629-650.
6. Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006; 110:503-524.
7. Schoemaker H, Morelli M, Deshmukh P, Yamamura HI. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res 1982; 248:396-401. (Pubitemid 12024439)
8. Itzhak Y, Roig-Cantisano A, Norenberg MD. Ontogeny of peripheral-type benzodiazepine receptors in cultured astrocytes and brain from rat. Brain Res Dev Brain Res 1995; 84:62-66.
9. Syapin PJ, Skolnick P. Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem 1979; 32:1047-1051. (Pubitemid 9133265)
10. Kugler W, Veenman L, Shandalov Y, Leschiner S, Spanier I, Lakomek M, et al. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 2008; 30:435-450.
11. Veenman L, Alten J, Linnemannstons K, Shandalov Y, Zeno S, Lakomek M, et al. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. Apoptosis 2010; 15:753-768.
12. Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 2007; 13:2385-2405. (Pubitemid 47321571)
13. Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 2009; 48:4652-4661.
14. Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr 2008; 40:199-205.
15. Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M, et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998; 241:426-434. (Pubitemid 28366568)
16. Drugan RC, Holmes PV, Scher DM, Luczak S, Oh H, Ferland RJ. Environmentally induced changes in peripheral benzodiazepine receptors are stressor and tissue specific. Pharmacol Biochem Behav 1995; 50: 551-562.
17. Fujimura Y, Hwang PM, Trout Iii H, Kozloff L, Imaizumi M, Innis RB, et al. Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195. Atherosclerosis 2008; 201:108-111.
18. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Chronic high fat, high cholesterol supplementation decreases 18 kDa Translocator Protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food Chem Toxicol 2010; 48:910-921.
19. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Dimethylbenz[alpha]anthracene induces oxidative stress and reduces the binding capacity of the mitochondrial 18-kDa translocator protein in rat aorta. Drug Chem Toxicol 2010; 33:337-347.
20. Zheng J, Boisgard R, Siquier-Pernet K, Decaudin D, Dolle F, Tavitian B. Differential expression of the 18 kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer. Mol Pharm 2011; 8:823-832.
21. Corsi L, Geminiani E, Baraldi M. Peripheral benzodiazepine receptor (PBR) new insight in cell proliferation and cell differentiation review. Curr Clin Pharmacol 2008; 3:38-45. (Pubitemid 351210963)
22. Vlodavsky E, Soustiel JF. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival. J Neurooncol 2007; 81:1-7. (Pubitemid 44963983)
23. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheraltype benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999; 59:831-842. (Pubitemid 29086736)
24. Gonda TA, Tu S, Wang TC. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009; 8:2005-2013.
25. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27:3437-3444.
26. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16: 91-102.
27. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006; 80:308-322. (Pubitemid 46107737)
28. Scarf AM, Kassiou M. The translocator protein. J Nucl Med 2011; 52: 677-680.
29. Levin E, Premkumar A, Veenman L, Kugler W, Leschiner S, Spanier I, et al. The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 2005; 44:9924-9935. (Pubitemid 41033459)
30. Shoukrun R, Veenman L, Shandalov Y, Leschiner S, Spanier I, Karry R, et al. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet Genomics 2008; 18:977-988.
31. Weisinger G, Kelly-Hershkovitz E,Veenman L, Spanier I, Leschiner S, Gavish M. Peripheral benzodiazepine receptor antisense knockout increases tumorigenicity of MA-10 Leydig cells in vivo and in vitro. Biochemistry 2004; 43:12315-12321. (Pubitemid 39280575)
32. Zeno S, Veenman L, Katz Y, Bode J, Gavish M, Zaaroor M. The 18 kDa mitochondrial translocator Protein (TSPO) prevents accumulation of protoporphyrin IX. A TSPO knockdown study. Curr Mol Med 2012 [Epub ahead of print].
33. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004; 25:1543-1549. (Pubitemid 39162720)
34. Volland S, Kugler W, Schweigerer L, Wilting J, Becker J. Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int J Cancer 2009; 125:2049-2057.
35. Erdlenbruch B, Alipour M, Fricker G, Miller DS, Kugler W, Eibl H, et al. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br J Pharmacol 2003; 140:1201-1210. (Pubitemid 38117424)
36. Delavoie F, Li H, Hardwick M, Robert J-C, Giatzakis C, Péranzi G, et al. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 2003; 42:4509-4519.
37. Soustiel JF, Palzur E, Vlodavsky E, Veenman L, Gavish M. The effect of oxygenation level on cerebral post-traumatic apoptotsis is modulated by the 18-kDa translocator protein (also known as peripheral-type benzodiazepine receptor) in a rat model of cortical contusion. Neuropathol Appl Neurobiol 2008; 34:412-423.
38. Rosenberg N, Rosenberg O, Weizman A, Leschiner S, Sakoury Y, Fares F, et al. In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells. J Bioenerg Biomembr 2011; 43:739-746.
39. Linan Z, Song J, Kim DA. Study on cancer-cell invasion based on the diffuse interface model. World Acad Sci Eng Technol 2010; 68:790-793.
40. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112:3-25.
41. Vignjevic D, Montagnac G. Reorganisation of the dendritic actin network during cancer cell migration and invasion. Semin Cancer Biol 2008; 18: 12-22. (Pubitemid 350266367)
42. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001; 27:427-430. (Pubitemid 32268425)
43. Pletcher MT, Nobukuni T, Fukuhara H, Kuramochi M, Maruyama T, Sekiya T, et al. Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23. Gene 2001; 273:181-189. (Pubitemid 32786911)
44. Giese A, Rief MD, Loo MA, Berens ME. Determinants of human astrocytoma migration. Cancer Res 1994; 54:3897-3904. (Pubitemid 24241213)
45. Lazzarini R, Sakai M, Costa-Pinto FA, Palermo-Neto J. Diazepam decreases leukocyte-endothelium interactions in situ. Immunopharmacol Immunotoxicol 2010; 32:402-409.
46. Ruff MR, Pert CB,Weber RJ,Wahl LM,Wahl SM, Paul SM. Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science 1985; 229:1281-1283. (Pubitemid 15021682)
47. Finnerty M, Marczynski TJ, Amirault HJ, Urbancic M, Andersen BR. Benzodiazepines inhibit neutrophil chemotaxis and superoxide production in a stimulus dependent manner; PK-11195 antagonizes these effects. Immunopharmacology 1991; 22:185-193.
48. Marino F, Cattaneo S, Cosentino M, Rasini E, Di Grazia L, Fietta AM, et al. Diazepam stimulates migration and phagocytosis of human neutrophils: possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium. Pharmacology 2001; 63:42-49. (Pubitemid 32623460)
49. Choi J, Ifuku M, Noda M, Guilarte TR. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia 2011; 59:219-230.
50. Veenman L, Bode J, Gaitner M, Caballero B, Peer L, Zeno S, et al. Effects of TSPO knockdown on glutamate receptors, transporters, and metabolism, as well as amyloid protein in glioblastoma cells, and on cell viability as affected by Abeta(1-42) and glutamate. Pharmacogenet Genomics 2012; 12. (in press)
51. Brown RC, Degenhardt B, Kotoula M, Papadopoulous V. Locationdependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis. Cancer Lett 2000; 156:125-132. (Pubitemid 30394669)
52. Mukhopadhyay S, Rajaratnam V, Mukherjee S, Das SK. Control of peripheral benzodiazepine receptor-mediated breast cancer in rats by soy protein. Mol Carcinog 2008; 47:310-319. (Pubitemid 351500157)
53. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor (to the nucleus) in human leukemia cells. Cancer Res 2005; 65: 11051-11060. (Pubitemid 41713376)
54. Pretner E, Amri H, Li W, Brown R, Lin CS, Makariou E, et al. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res 2006; 26:9-22. (Pubitemid 43206054)
55. Yeliseev AA, Kaplan S. TspO of Rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor. J Biol Chem 2000; 275:5657-5667. (Pubitemid 30115205)
56. Chapalain A, Chevalier S, Orange N, Murillo L, Papadopoulos V, Feuilloley MG. Bacterial ortholog of mammalian translocator protein (TSPO) with virulence regulating activity. PLoS One 2009; 4:e6096.
57. Papadopoulos V, Liu J, Culty M. Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 2007; 265-266:59-64. (Pubitemid 46273951)
58. Veenman L, Gavish M. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med 2011; 52:1265-1277.
59. Berkovich A, Ferrarese C, Cavaletti G, Alho H, Marzorati C, Bianchi G, et al. Topology of two DBI receptors in human lymphocytes. Life Sci 1993; 52:1265-1277.
60. Cosentino M, Marino F, Cattaneo S, Di Grazia L, Francioli C, Fietta AM, et al. Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function. J Leukoc Biol 2000; 67:637-643.
61. Gandolfo P, Louiset E, Patte C, Leprince J, Masmoudi O, Malagon M, et al. The triakontatetraneuropeptide TTN increases [CA2+] in rat astrocytes through activation of peripheral-type benzodiazepine receptors. Glia 2001; 35:90-100.
62. Marino F, Cosentino M, Fietta AM, Ferrari M, Cattaneo S, Frigo G, et al. Interleukin-8 production induced by the endozepine triakontatetraneuropeptide in human neutrophils: role of calcium and pharmacological investigation of signal transduction pathways. Cell Signal 2003; 15:511-517. (Pubitemid 36287672)
63. Chelli B, Salvetti A, Da Pozzo E, Rechichi M, Spinetti F, Rossi L, et al. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells. J Cell Biochem 2008; 105:712-723.
64. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline- carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 2008; 74:443-453.
65. Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochem Pharmacol 2007; 73:491-503. (Pubitemid 46038854)
66. Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N, et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 2005; 24: 7503-7513. (Pubitemid 41638026)
67. Panickar KS, Jayakumar AR, Rama Rao KV, Norenberg MD. Downregulation of the 18-kDa translocator protein: effects on the ammonia-induced mitochondrial permeability transition and cell swelling in cultured astrocytes. Glia 2007; 55:1720-1727. (Pubitemid 47612858)
68. Rechichi M, Salvetti A, Chelli B, Costa B, Da Pozzo E, Spinetti F, et al. TSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cells. Biochim Biophys Acta 2008; 1782:118-125.
69. Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun 1999; 265:457-461.
70. Morris RL, Varnes ME, Kenney ME, Li YS, Azizuddin K, McEnery MW, Oleinick NL. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Photochem Photobiol 2002; 75:652-661.
71. Strohmeier R, Roller M, Sänger N, Knecht R, Kuhl H. Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells. Biochem Pharmacol 2002; 64:99-107. (Pubitemid 34775180)
72. Marselli L, Trincavelli L, Santangelo C, Lupi R, Del Guerra S, Boggi U, et al. The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets. Eur J Endocrinol 2004; 151:207-214. (Pubitemid 39207016)
73. Ceruti S, Mazzola A, Abbracchio MP. Resistance of human astrocytoma cells to apoptosis induced by mitochondria-damaging agents: possible implications for anticancer therapy. J Pharmacol Exp Ther 2005; 314: 825-837. (Pubitemid 41043868)
74. Wall SJ, Yasuda RP, Li M, Wolfe BB. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Mol Pharmacol 1991; 40:783-789.